[14C]-AZD5305 (therapeutic dose) clinical trials

AZD5305 hADME in Patients With Advanced Solid Malignancies

This study is looking at how a new drug, Saruparib, is absorbed, used, and leaves the body in people with advanced cancers. It aims to understand the drug's journey through the body to help guide future treatments.